Although you will probably argue vociferously that the company has a great future, behind closed doors you probably feel that you were conned: you took a huge risk, the drug got FDA approval, but the share price is a big yawn. Eventually, you will have to admit (privately, if not publicly) that this drug has no chance whatsoever to capture more than a minuscule share of the market for aesthetic medicine.
Why would i i'm green, and holding for better things to come. No worries here. Flipping is for green horns.
Market Data 
Markets 
AI
